These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 22730343

  • 1. Serum cotinine as a biomarker of tobacco exposure and the association with treatment response in early rheumatoid arthritis.
    Maska LB, Sayles HR, O'Dell JR, Curtis JR, Bridges SL, Moreland LW, Cofield SS, Mikuls TR.
    Arthritis Care Res (Hoboken); 2012 Dec; 64(12):1804-10. PubMed ID: 22730343
    [Abstract] [Full Text] [Related]

  • 2. A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial.
    Moreland LW, O'Dell JR, Paulus HE, Curtis JR, Bathon JM, St Clair EW, Bridges SL, Zhang J, McVie T, Howard G, van der Heijde D, Cofield SS, TEAR Investigators.
    Arthritis Rheum; 2012 Sep; 64(9):2824-35. PubMed ID: 22508468
    [Abstract] [Full Text] [Related]

  • 3. Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial.
    Navarro-Millán I, Charles-Schoeman C, Yang S, Bathon JM, Bridges SL, Chen L, Cofield SS, Dell'Italia LJ, Moreland LW, O'Dell JR, Paulus HE, Curtis JR.
    Arthritis Rheum; 2013 Jun; 65(6):1430-8. PubMed ID: 23460074
    [Abstract] [Full Text] [Related]

  • 4. Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trial.
    O'Dell JR, Curtis JR, Mikuls TR, Cofield SS, Bridges SL, Ranganath VK, Moreland LW, TEAR Trial Investigators.
    Arthritis Rheum; 2013 Aug; 65(8):1985-94. PubMed ID: 23686414
    [Abstract] [Full Text] [Related]

  • 5. Rheumatoid Arthritis Treatment After Methotrexate: The Durability of Triple Therapy Versus Etanercept.
    Peper SM, Lew R, Mikuls T, Brophy M, Rybin D, Wu H, O'Dell J.
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1467-1472. PubMed ID: 28388820
    [Abstract] [Full Text] [Related]

  • 6. Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritis.
    Fleischmann R, Koenig AS, Szumski A, Nab HW, Marshall L, Bananis E.
    Rheumatology (Oxford); 2014 Nov; 53(11):1984-93. PubMed ID: 24907147
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of etanercept 50 mg twice a week in patients with rheumatoid arthritis who had a suboptimal response to etanercept 50 mg once a week: results of a multicenter, randomized, double-blind, active drug-controlled study.
    Weinblatt ME, Schiff MH, Ruderman EM, Bingham CO, Li J, Louie J, Furst DE.
    Arthritis Rheum; 2008 Jul; 58(7):1921-30. PubMed ID: 18576334
    [Abstract] [Full Text] [Related]

  • 8. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes.
    Genovese MC, Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Wasko MC, Moreland LW, Weaver AL, Markenson J, Cannon GW, Spencer-Green G, Finck BK.
    Arthritis Rheum; 2002 Jun; 46(6):1443-50. PubMed ID: 12115173
    [Abstract] [Full Text] [Related]

  • 9. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.
    van der Heijde D, Klareskog L, Rodriguez-Valverde V, Codreanu C, Bolosiu H, Melo-Gomes J, Tornero-Molina J, Wajdula J, Pedersen R, Fatenejad S, TEMPO Study Investigators.
    Arthritis Rheum; 2006 Apr; 54(4):1063-74. PubMed ID: 16572441
    [Abstract] [Full Text] [Related]

  • 10. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.
    Smolen JS, Nash P, Durez P, Hall S, Ilivanova E, Irazoque-Palazuelos F, Miranda P, Park MC, Pavelka K, Pedersen R, Szumski A, Hammond C, Koenig AS, Vlahos B.
    Lancet; 2013 Mar 16; 381(9870):918-29. PubMed ID: 23332236
    [Abstract] [Full Text] [Related]

  • 11. Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: results from the TEAR Trial.
    Curtis JR, McVie T, Mikuls TR, Reynolds RJ, Navarro-Millán I, O'Dell J, Moreland LW, Bridges SL, Ranganath VK, Cofield SS.
    J Rheumatol; 2013 May 16; 40(5):572-8. PubMed ID: 23588939
    [Abstract] [Full Text] [Related]

  • 12. Two-year clinical and radiographic results with combination etanercept-methotrexate therapy versus monotherapy in early rheumatoid arthritis: a two-year, double-blind, randomized study.
    Emery P, Breedveld F, van der Heijde D, Ferraccioli G, Dougados M, Robertson D, Pedersen R, Koenig AS, Freundlich B, Combination of Methotrexate and Etanercept in Early Rheumatoid Arthritis Trial Group.
    Arthritis Rheum; 2010 Mar 16; 62(3):674-82. PubMed ID: 20187135
    [Abstract] [Full Text] [Related]

  • 13. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
    O'Dell JR, Leff R, Paulsen G, Haire C, Mallek J, Eckhoff PJ, Fernandez A, Blakely K, Wees S, Stoner J, Hadley S, Felt J, Palmer W, Waytz P, Churchill M, Klassen L, Moore G.
    Arthritis Rheum; 2002 May 16; 46(5):1164-70. PubMed ID: 12115219
    [Abstract] [Full Text] [Related]

  • 14. Triple Oral Therapy Versus Antitumor Necrosis Factor Plus Methotrexate (MTX) in Patients with Rheumatoid Arthritis and Inadequate Response to MTX: A Systematic Literature Review.
    Mary J, De Bandt M, Lukas C, Morel J, Combe B.
    J Rheumatol; 2017 Jun 16; 44(6):773-779. PubMed ID: 28412710
    [Abstract] [Full Text] [Related]

  • 15. Preliminary evaluation in rheumatoid arthritis activity in patients treated with TNF-alpha blocker plus methotrexate versus methotrexate or leflunomide alone.
    Wisłowska M, Jakubicz D.
    Rheumatol Int; 2007 May 16; 27(7):641-7. PubMed ID: 17235556
    [Abstract] [Full Text] [Related]

  • 16. Clinical outcome in patients with rheumatoid arthritis switched to tocilizumab after etanercept or infliximab failure.
    Wakabayashi H, Hasegawa M, Nishioka Y, Minami Y, Nishioka K, Sudo A.
    Clin Rheumatol; 2013 Feb 16; 32(2):253-9. PubMed ID: 23179002
    [Abstract] [Full Text] [Related]

  • 17. Combination etanercept and methotrexate provides better disease control in very early (<=4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET study.
    Emery P, Kvien TK, Combe B, Freundlich B, Robertson D, Ferdousi T, Bananis E, Pedersen R, Koenig AS.
    Ann Rheum Dis; 2012 Jun 16; 71(6):989-92. PubMed ID: 22402142
    [Abstract] [Full Text] [Related]

  • 18. Therapies for active rheumatoid arthritis after methotrexate failure.
    O'Dell JR, Mikuls TR, Taylor TH, Ahluwalia V, Brophy M, Warren SR, Lew RA, Cannella AC, Kunkel G, Phibbs CS, Anis AH, Leatherman S, Keystone E, CSP 551 RACAT Investigators.
    N Engl J Med; 2013 Jul 25; 369(4):307-18. PubMed ID: 23755969
    [Abstract] [Full Text] [Related]

  • 19. Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.
    Machado DA, Guzman RM, Xavier RM, Simon JA, Mele L, Pedersen R, Ferdousi T, Koenig AS, Kotak S, Vlahos B.
    J Clin Rheumatol; 2014 Jan 25; 20(1):25-33. PubMed ID: 24356474
    [Abstract] [Full Text] [Related]

  • 20. The Effect of Reduced or Withdrawn Etanercept-methotrexate Therapy on Patient-reported Outcomes in Patients with Early Rheumatoid Arthritis.
    Wiland P, Dudler J, Veale D, Tahir H, Pedersen R, Bukowski J, Vlahos B, Williams T, Gaylord S, Kotak S.
    J Rheumatol; 2016 Jul 25; 43(7):1268-77. PubMed ID: 27252426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.